An Adaptive Physiologically Based Pharmacokinetic–Driven Design to Investigate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Molibresib (GSK525762) in Healthy Female Volunteers

Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies

(2015) Lichuan Liu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Itraconazole and Clarithromycin as Ketoconazole Alternatives for Clinical CYP3A Inhibition Studies

(2014) A B Ke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Liver injury associated with ketoconazole: Review of the published evidence

(2014) H. Karl Greenblatt et al.   JOURNAL OF CLINICAL PHARMACOLOGY

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

(2011) Jake E. Delmore et al.   CELL

Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains

(2011) Chun-wa Chung et al.   JOURNAL OF MEDICINAL CHEMISTRY

Targeting MYC dependence in cancer by inhibiting BET bromodomains

(2011) J. A. Mertz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Suppression of inflammation by a synthetic histone mimic

(2010) Edwige Nicodeme et al.   NATURE

Effect of Different Durations of Ketoconazole Dosing on the Single-Dose Pharmacokinetics of Midazolam: Shortening the Paradigm

(2009) S. A. Stoch et al.   JOURNAL OF CLINICAL PHARMACOLOGY